Looking ready for another move, sellers dwindling. Buyers building, and a heap of subscription $$ being returned, to buy on market if still wanting in.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025